Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Tags Healthy Returns Zealand Pharma A/S Augmedix Inc
From CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
Tags Biogen Inc Science Biotechnology
From CNBC.com News
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Business News Biotech and Pharmaceuticals Eli Lilly and Co
From CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
Tags Pharmaceuticals Health & Science Biotechnology
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Breaking News: Business Business Biotech and Pharmaceuticals
From CNBC.com News
Jim Cramer supports megacaps for the long term, even as Wall Street continues to sell
Tags Eli Lilly and Co U/S/ Markets Markets
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Netflix Inc Eli Lilly and Co Daily Open
From CNBC.com News
CNBC Daily Open: Rising geopolitical risk
Tags Pharmaceuticals Meta Platforms Inc World Markets
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Zealand Pharma A/S Roche Holding AG Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags Healthy Returns Health & Science Novo Nordisk A/S
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Eli Lilly and Co Novo Nordisk A/S Health & Science
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Breaking News: Business Pfizer Inc Business
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Investment strategy Business Hims & Hers Health Inc
From CNBC.com News
Jim Cramer reviews 8 companies that could top $1 trillion in market cap
Tags Investment Strategy Berkshire Hathaway Inc Visa Inc
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Health & Science Politics Sanofi SA
From CNBC.com News
Companies besides tech can reach megacap status, Jim Cramer says
Tags Apple Inc Stock Picks Meta Platforms Inc
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Investment strategy Diabetes Prescription drug costs
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Novo Nordisk A/S Cigna Corp Viking Therapeutics Inc
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Market Outlook Daily Open Alzheimer's disease
From CNBC.com News
CNBC Daily Open: Tesla soars, S&P closes above 5,500
Tags Tesla Inc Electric vehicles Medication
From CNBC.com News
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
Tags Eli Lilly and Co US: News Companies
From CNBC.com News
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags US: News ETF Edge Alnylam Pharmaceuticals Inc
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Healthy Returns Zealand Pharma A/S Health care industry
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags Investment Strategy Stock Picks U/S/ Markets
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Business Business News China Economy
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Health care industry Biotech and Pharmaceuticals Business News
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Business News Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Europe Markets Novo Nordisk A/S Zealand Pharma A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Labor economy Health care industry Biotech and Pharmaceuticals
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Pharmaceuticals Health & Science Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.